Hip Denervation in Juvenile Idiopathic Arthritis With Hip Arthritis

Summary

Patients having juvenile idiopathic arthritis (according to ILAR criteria) with hip arthritis were divided into 3 groups. Group 1 received hip denervation and group 2 controlled and received a subcutaneous injection of saline, and group 3 received intra-articular triamcinolone. Outcome measures included pain, tenderness, range of motion, SOLAR, HARISS score. These outcomes were measured at baseline, 2 weeks, and 16 weeks

Timeline

Start

2021-01-06

Primary completion

2021-04-06

Completion

2021-04-06

Drugs

Indications